Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate 4.34% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Dec 24
3
Risky -
4
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.83%
0%
-5.83%
6 Months
-13.04%
0%
-13.04%
1 Year
-54.27%
0%
-54.27%
2 Years
-82.26%
0%
-82.26%
3 Years
-56.74%
0%
-56.74%
4 Years
-96.24%
0%
-96.24%
5 Years
-95.63%
0%
-95.63%
DocMorris Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-7.19%
EBIT Growth (5y)
4.34%
EBIT to Interest (avg)
-5.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.71
Sales to Capital Employed (avg)
1.60
Tax Ratio
5.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.66
EV to EBIT
-4.18
EV to EBITDA
-8.56
EV to Capital Employed
0.69
EV to Sales
0.37
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.61%
ROE (Latest)
-20.25%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Bearish
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.93%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,017.00
969.50
4.90%
Operating Profit (PBDIT) excl Other Income
-45.90
-32.40
-41.67%
Interest
20.00
19.90
0.50%
Exceptional Items
0.10
-2.00
105.00%
Consolidate Net Profit
-97.30
-117.60
17.26%
Operating Profit Margin (Excl OI)
-90.00%
-78.20%
-1.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 4.90% vs 4.14% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 17.26% vs 31.27% in Dec 2023
About DocMorris Ltd. 
DocMorris Ltd.
Retailing
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Company Coordinates 
Company Details
Walzmuehlestrasse 60 , FRAUENFELD None : 8500
Registrar Details






